SLEEP MEDICINE

As new dual orexin receptor antagonists become available to treat sleep disorders, time will tell whether this new class of drugs will fulfill its promise for a disorder plagued by underdiagnosis and indifference.
Following his review of available pharmacologic agents, an expert elucidates selection of therapy for elderly patients with insomnia.

SAP Partner Banner

About NeurologyLive's Sleep Medicine Clinical Focus page:

Content found within NeurologyLive's Sleep Medicine Clinical Focus page offers the latest and most valuable information on emerging therapies for sleep disturbances and disorders. Articles include relevant updates from the floor of the most notable neurology conferences and annual meetings, as well as video interviews with the leading experts in neurology, especially those specializing in the treatment of narcolepsy and obstructive sleep apnea.
 
A lack of sleep has proven to be damaging to physical, mental, and emotional health, and the content offered on this page, which includes breaking news coverage of approvals from the U.S. Food and Drug Administration (FDA), key takeaways from recent clinical trials of new and emerging therapies, and notifications of updates to clinical guidelines, is intended to dramatically improve patient care.